Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dismed Criticare is an Indian pharmaceutical company that specializes in the development and marketing of critical care products, particularly high-end injectables. The company's portfolio is focused on life-saving medications used in intensive care units (ICUs) and hospital settings, including a wide range of antibiotics, anti-fungals, and analgesics. Key products in their commercial lineup include generic versions of Meropenem, Caspofungin, and Piperacillin + Tazobactam. Dismed Criticare aims to provide high-quality, affordable therapeutic solutions to healthcare providers and institutions across India. The company operates primarily in the institutional sales segment, serving major hospitals and medical centers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dismet Criticare.